Negative regulation of Rho protein signal transduction

pathway activity — cross-omics
GO:0035024Cross-omicsRNA → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Negative regulation of Rho protein signal transduction pathway is significantly associated with the protein abundance of multiple proteins, with the CCRCC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated proteins across cancer lineages are RPS2, FRZB, and PHLDB1_S404, each associated with the pathway in up to 8 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Negative regulation of Rho protein signal transduction activity versus RPS2 in CCRCC (Pearson r = -0.26).

Pathway-associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
CCRCCRPS2 →-0.200-0.040.001<.00138
BRCAFRZB →+0.733+0.042<.001<.00138
BRCAPHLDB1_S404 →+0.420+0.031.003.00238
BRCAFERMT2 →+0.640+0.042<.001<.00138
CCRCCPRKG1 →+0.517+0.046<.001<.00138
COADRAI14 →+0.276+0.041.005<.00138
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0035024 vs RPS2 — CCRCC

Per-sample scatter of Negative regulation of Rho protein signal transduction activity vs RPS2 in CCRCC.

Explore this scatter interactively →

Exploration